Clinical Trial: Evaluation of Efficacy and Safety of Immunotherapy in Elderly Patients with Advanced Non-Small Cell Lung Cancer Based on Multimodal Data (China)

China, Sept. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation of Efficacy and Safety of Immunotherapy in Elderly Patients with Advanced Non-Small Cell Lung Cancer Based on Multimodal Data'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133219

Registration Time: 2026/09/23

Type: Observational study

Primary Sponsor: Beijing Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344329

Published by HT Digital Content Services with permission from Health Daily Digest....